Study suggests coronary stents not harmful to patients with history of metal allergy
Cardiologists have long grappled with how to best manage patients with coronary artery disease who report skin hypersensitivity to nickel or other metal components found in stents -- small tubes placed in narrowed or weakened ...
Cardiology
Apr 16, 2012 |
not rated yet |
0
|
Drug-Eluting stents reduce risk of thrombosis
(HealthDay) -- Cobalt-chromium everolimus eluting stents (CoCr-EES) are associated with a significantly lower rate of stent thrombosis within two years of implantation, compared with other bare-metal and drug-eluting ...
Cardiology
Mar 23, 2012 |
not rated yet |
0
|
Study examines stent implantation compared to initial medical therapy for stable coronary disease
A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical ...
Cardiology
Feb 27, 2012 |
not rated yet |
0
|
World's first bedside genetic test proves effective
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...
Genetics
Nov 09, 2011 |
not rated yet |
0
|
Researchers find gene variants that cause stent thrombosis in people with coronary artery disease
In a first-of-its-kind study, researchers from Mount Sinai School of Medicine have discovered several gene variants contributing to early stent thrombosis (ST), a devastating and often deadly complication after coronary stent ...
Genetics
Oct 25, 2011 |
not rated yet |
0
|
Drug-Eluting stents offer no advantage for A-Fib patients
(HealthDay) -- Drug-eluting stents (DESs) do not seem to offer advantages over bare-metal stents (BMSs) for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with ...
Cardiology
Jun 22, 2012 |
not rated yet |
0
Post-SES implantation, statins prevent late revascularization
(HealthDay) -- For patients who undergo sirolimus-eluting stent (SES) implantation, use of statin therapy is associated with a reduced risk of late target lesion revascularization (TLR), according to a study ...
Cardiology
May 12, 2012 |
not rated yet |
0
Coronary artery stenting viable palliative option for infants and toddlers
Percutaneous coronary intervention (PCI) is not a generally accepted option for infants or toddlers with acute coronary syndrome. However, a new report published in the August issue of Catheterization and Cardiovascular In ...
Cardiology
Aug 22, 2011 |
not rated yet |
0
Study finds drug-eluting stents exhibit some benefits over bare-metal stents in patients over 80, though both demonstrat
Rarely tested in patients over the age of 80, a study found that drug-eluting stents exhibited some benefits over bare-metal stents, though both types of stents demonstrated a clinical benefit. Results of the XIMA trial were ...
Cardiology
Oct 26, 2012 |
not rated yet |
0
Personalized antiplatelet treatment improves outcome after PCI
Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Drug eluting stents used less often in women than men
Drug eluting stents (DES) are used less often in women treated with percutaneous coronary intervention (PCI) for coronary artery disease than men treated with PCI for the same condition, according to research presented today, ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
New 'real-world' reassuring data from the SCAAR registry
A registry -which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease- has found that PCI implantations using a new generation of ...
Cardiology
Jan 09, 2012 |
not rated yet |
0
Results of the ROTAXUS trial reported at TCT 2011
A clinical trial testing the efficacy of rotational atherectomy (or rotablation, a process of drilling through plaque deposits) prior to implantation of a drug-eluting stent found that the process was not superior to standard ...
Cardiology
Nov 11, 2011 |
not rated yet |
0
Results of the DESERT registry reported at TCT 2011
The risk of late stent thrombosis (ST) in the first generation of drug-eluting stents continues for up to seven years after implantation, and certain types of patients, including smokers and those who are younger, are at ...
Cardiology
Nov 09, 2011 |
not rated yet |
0
Extending the effective lifetime of stents
Implanted stents can reopen obstructed arteries, but regrowth of cells into the vessel wall can entail restenosis. Research at LMU now shows that an antimicrobial peptide inhibits restenosis and promotes vascular healing. ...
Medical research
Oct 06, 2011 |
not rated yet |
0
